Climb Bio Inc CLYM
9.75 USD +0.01 (+0.10%)
At closeNov 3, 2026, 4:01 PM EST
9.75 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
9.56 Day range 10.07
1.64 52-week range 18.33
- YTD
- +143.75%
- 1 year
- +387.50%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 22.86 +134.4% upside
Now 9.75
- Target (low)
- 18.00
- Target (mean)
- 22.86
- Target (high)
- 35.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy2
- Buy12
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 15
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.195 | -0.23 – -0.16 | -0.19 | -2.6% | 0 | 0.0% | 8 |
| Next quarter | -0.2075 | -0.25 – -0.16 | -0.26 | +20.2% | 0 | 0.0% | 8 |
| Current year | -0.77875 | -0.85 – -0.70 | -0.88 | +11.5% | 0 | 0.0% | 8 |
| Next year | -1.05 | -1.44 – -0.76 | -0.77875 | -35.4% | 535.71K | 0.0% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 19, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 27, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jun 24, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jun 11, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 8, 2026 | Guggenheim | Initiated | — | Buy |
| Jun 8, 2026 | BTIG | Reiterated | Buy | Buy |
| May 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 8, 2026 | Wedbush | Maintained | Outperform | Outperform |
| May 6, 2026 | BTIG | Maintained | Buy | Buy |
| May 5, 2026 | Chardan Capital | Initiated | — | Buy |
| Apr 21, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 15, 2026 | Mizuho | Initiated | — | Outperform |
| Apr 8, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 24, 2026 | B. Riley Securities | Initiated | — | Buy |
| Mar 18, 2026 | Truist Securities | Initiated | — | Buy |
| Mar 11, 2026 | Raymond James | Initiated | — | Strong Buy |
| Mar 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 6, 2026 | Baird | Maintained | Outperform | Outperform |
| Mar 5, 2026 | Wedbush | Initiated | — | Outperform |
| Feb 13, 2026 | Piper Sandler | Initiated | — | Overweight |
| Dec 30, 2025 | Freedom Broker | Initiated | — | Buy |
| Dec 18, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 16, 2025 | William Blair | Initiated | — | Outperform |
| Oct 16, 2025 | BTIG | Reiterated | Buy | Buy |
| Oct 13, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 30, 2025 | BTIG | Maintained | Buy | Buy |